If you would like to ask our webinar guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCeps Regulatory News (CEPS)

Share Price Information for Ceps (CEPS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 19.00
Bid: 17.00
Ask: 21.00
Change: 0.00 (0.00%)
Spread: 4.00 (23.529%)
Open: 19.00
High: 19.00
Low: 19.00
Prev. Close: 18.50
CEPS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition & Placing

2 Apr 2012 07:00

RNS Number : 5291A
CEPS PLC
02 April 2012
 



2 April 2012

CEPS PLC

 ("CEPS" or the "Company")

 

Acquisition & Placing

 

Acquisition

 

The Board of CEPS announces that the Company is conditionally proposing to acquire a 21.4 per cent. shareholding in NG42 Acquisitions Limited ("NG42") for an aggregate cash consideration of £500,000 (the "NG42 Acquisition"). The NG42 Acquisition is subject only to completion of the proposed placing by CEPS, details of which are set out below.

 

NG42 is a newly incorporated company formed to acquire the entire issued share capital of CEM Group Limited ("CEM"). The acquisition of CEM by NG42 (the "CEM Acquisition") was completed on 31 March 2012.

 

CEM owns 100% of CEM Press Limited ("CEMP"), a manufacturer of fabric and wallpaper pattern books with a focus on the high-end fabric and wallpaper market. CEMP's products are sold both in the UK and overseas. In the year ended 31 December 2010, CEMP's sales were £2,867,000 and profit before tax was £359,000. At 31 December 2010, net assets were £423,000. Trading performance of CEMP in 2011 was in line with management's expectations for the year.

 

The consideration for the CEM Acquisition is £2,377,200, comprising a mix of cash, loan notes and consideration shares. Other third party investors have invested an aggregate of £1,400,000 in cash in NG42, at the same price per NG42 share as is being paid by CEPS, for approximately 59.8% of the issued share capital of NG42.

 

The NG42 Acquisition fits well with CEPS' strategy of acquiring interests in established, cash generative businesses and utilises a funding structure aimed at maximising the return on equity employed.

 

The Directors of CEPS believe that the NG42 Acquisition will be a valuable addition to the Company's portfolio of investments.

 

 

Placing

 

In order to finance the NG42 Acquisition, the Company is proposing to issue 2,500,000 new ordinary shares of 5 pence per share (the "Placing Shares") at a price of 20 pence per share (the "Placing Price") to new and existing investors, including certain CEPS Directors, raising gross proceeds of £500,000 (the "Placing"). The Placing is subject to admission of the Placing Shares to trading on AIM ("Admission").

 

The Placing Price is equal to the closing mid-market price of 20 pence per CEPS share as at 30 March 2012, being the last business day prior to this announcement.

 

Application for Admission for the Placing Shares has been made and Admission is expected to occur on or around 3 April 2012. Once issued, the Placing Shares will rank pari passu with the existing ordinary shares in the Company.

 

Following the issue of the Placing Shares, the issued share capital of the Company will comprise 10,814,310 ordinary shares of 5 pence each.

 

 

Related Party Transactions

 

David Horner and Richard Organ, who are directors of the Company, Mark Thistlethwayte and Chelverton Growth Trust, who are substantial shareholders in the Company, and Chelverton Asset Management, of which David Horner is a director, have agreed to subscribe for Placing Shares at the Placing Price. These subscriptions are Related Party Transactions as defined in the AIM Rules for Companies. Details of their respective subscriptions and resultant shareholdings are set out in the table below.

 

 

Related party

Prior to the Placing

Number of Placing Shares acquired

 

Following the Placing

Shareholding

%

Shareholding

%

David Horner

1,087,110

13.08

750,000

1,837,110

16.99

Richard Organ

169,333

2.04

50,000

219,333

2.03

Mark Thistlethwayte

1,290,000

15.52

430,000

1,720,000

15.90

Chelverton Growth Trust

1,000,000

12.03

750,000

1,750,000

16.18

Chelverton Asset Management

-

-

500,000

500,000

4.62

 

 

Peter Cook, Geoff Martin and Vivien Langford, being the independent directors of the Company, consider, having consulted with Cairn Financial Advisers LLP, the Company's nominated adviser, that the terms of the transactions are fair and reasonable insofar as the Company's shareholders are concerned.

 

 

Trading update

 

As indicated in the half yearly report in September 2011, the trading environment in the second half has continued to be difficult. Consequently, the Directors do not anticipate that the second half results will show any significant change to the first half.

 

The Directors anticipate that the preliminary results of the Company for the year ended 31 December 2011 will be published on or around 6 June 2012.

 

 

Enquiries

 

CEPS PLC

Peter Cook, Group MD

 

+44 1225 483030

 

Cairn Financial Advisers LLP

Tony Rawlinson / Avi Robinson

 

+44 20 7148 7900

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEAKDEDELAEFF
Date   Source Headline
14th May 20247:00 amRNSFurther re: Share Capital Reduction Update
3rd May 202412:30 pmRNSSignificant Shareholder
3rd May 20247:00 amRNSFinal Results
1st May 20244:30 pmRNSFurther re: Share Capital Reduction Update
1st May 202411:00 amRNSShare Capital Reduction Update
18th Apr 20243:46 pmRNSHolding(s) in Company
18th Apr 20247:00 amRNSPension Scheme Update
20th Mar 20244:20 pmRNSResult of General Meeting
18th Mar 20247:00 amRNSConcert Party Update
1st Mar 20247:00 amRNSProposed Share Capital Reduction and Notice of AGM
5th Feb 20247:00 amRNSTrading Update
3rd Jan 20244:30 pmRNSHolding(s) in Company
28th Nov 20234:06 pmRNSChelverton Growth Trust Update
8th Nov 20232:15 pmRNSShare Price Movement
19th Oct 20233:46 pmRNSVale Brothers - associate company corporate update
11th Oct 20237:00 amRNSVale Brothers - associate company corporate update
27th Sep 20233:48 pmRNSVale Brothers - associate company corporate update
5th Sep 20237:00 amRNSHalf-year Report
12th Jun 20232:31 pmRNSResult of AGM
5th May 20237:00 amRNSFinal Results and Notice of AGM
21st Mar 20235:29 pmRNSDirector's dealings
29th Sep 20227:00 amRNSHalf-year Report
13th Jun 202212:01 pmRNSResult of AGM
13th Jun 202210:58 amRNSPension scheme and general trading update
10th May 20227:00 amRNSFinal Results
3rd May 20227:00 amRNSExtension of existing related party loan
12th Apr 20229:34 amRNSBusiness and Assets Purchase by Aford Awards Ltd
13th Dec 20213:00 pmRNSPension Scheme, Loan Extension & Trading Update
30th Sep 20215:32 pmRNSHolding(s) in Company
30th Sep 20217:00 amRNSTotal Voting Rights
28th Sep 20213:15 pmRNSHolding(s) in Company
28th Sep 20213:13 pmRNSHolding(s) in Company
28th Sep 20212:55 pmRNSHolding(s) in Company
17th Sep 20217:00 amRNSResult of Placing
16th Sep 20214:35 pmRNSProposed Placing, Directors' Dealings & RPTs
16th Sep 20214:35 pmRNSHalf-year Report
3rd Sep 20217:00 amRNSBusiness and Assets Purchases by Aford Awards Ltd
29th Jun 20212:27 pmRNSFundraise by Hickton Group Ltd
22nd Jun 202112:11 pmRNSResult of AGM
25th May 20217:00 amRNSFinal Results
20th May 20211:54 pmRNSThird party loan and related party transaction
20th Apr 20211:10 pmRNSInterims 2020 correction
15th Apr 20212:22 pmRNSHickton Group Limited - CBIL
15th Mar 20213:53 pmRNSAcquisition of Millington Lord Limited
1st Mar 20217:05 amRNSProgressive publishes new research
25th Jan 20216:27 pmRNSDirector's dealings
22nd Jan 20217:00 amRNSRelated Party Transaction
23rd Dec 202012:21 pmRNSDirector's dealings
18th Dec 20209:18 amRNSMerger of Davies Odell with Vale Brothers
5th Nov 202010:30 amRNSRelated Party Transaction

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.